Current therapy for bronchiolitis

Archives of Disease in Childhood

Volumn 97, Issue 9, 2012, Pages 827-830

  Nagakumar, Prasad ^a   Doull, Iolo ^a  

^a CHILDREN S HOSPITAL FOR WALES   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ADRENERGIC RECEPTOR STIMULATING AGENT; ANTIBIOTIC AGENT; ANTIVIRUS AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; DEOXYRIBONUCLEASE; DEXAMETHASONE; HELIOX; IPRATROPIUM BROMIDE; MONTELUKAST; OXYGEN; SALBUTAMOL; SODIUM CHLORIDE;

ARTIFICIAL VENTILATION; ASSISTED VENTILATION; BREAST FEEDING; BRONCHIOLITIS; ENTERIC FEEDING; EXTRACORPOREAL OXYGENATION; FLUID INTAKE; HEATED HUMIDIFIED HIGH FLOW NASAL CANNULA; INFANT DISEASE; INFANT FEEDING; INTENSIVE CARE; INTRAVENOUS ADMINISTRATION; LENGTH OF STAY; LUNG FUNCTION TEST; NOSE FEEDING; OXYGEN SATURATION; OXYGEN SUPPLY; OXYGEN THERAPY; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; REVIEW;

ANTI-BACTERIAL AGENTS; ANTIVIRAL AGENTS; BRONCHIOLITIS; FLUID THERAPY; HELIUM; HUMANS; OXYGEN; OXYGEN INHALATION THERAPY; RESPIRATION, ARTIFICIAL; RESPIRATORY SYSTEM AGENTS; SALINE SOLUTION, HYPERTONIC;

EID: 84866119915     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/archdischild-2011-301579     Document Type: Review

References (48)

1. Reynolds EO, Cook CD. The treatment of bronchiolitis. J Pediatr 1963;63:1205-7.
2. SIGN. Scottish Intercollegiate Guideline Network. 91: Bronchiolitis in Children. http:// www.sign.ac.uk/pdf/sign91.pdf 2006 (accessed 1 June 2012).
3. Diagnosis and management of bronchiolitis. Pediatrics 2006;118:1774-93.
4. Handforth J, Friedland JS, Sharland M. Basic epidemiology and immunopathology of RSV in children. Paediatr Respir Rev 2000;1:210-14.
5. Shay DK, Holman RC, Newman RD, et al. Bronchiolitis-associated hospitalizations among US children, 1980-1996. JAMA 1999;282:1440-6. (Pubitemid 29493797)
6. Deshpande SA, Northern V. The clinical and health economic burden of respiratory syncytial virus disease among children under 2 years of age in a defi ned geographical area. Arch Dis Child 2003;88:1065-9. (Pubitemid 38064480)
7. Hall CB, Weinberg GA, Iwane MK, et al. The burden of respiratory syncytial virus infection in young children. N Engl J Med 2009;360:588-98.
8. Hall CB. Respiratory syncytial virus: A continuing culprit and conundrum. J Pediatr 1999;135:2-7.
9. Hall CB, Walsh EE, Long CE, et al. Immunity to and frequency of reinfection with respiratory syncytial virus. J Infect Dis 1991;163:693-8.
10. Stockman LJ, Curns AT, Anderson LJ, et al. Respiratory syncytial virus-associated hospitalizations among infants and young children in the United States, 1997-2006. Pediatr Infect Dis J 2012;31:5-9.
11. Spencer N, Logan S, Scholey S, et al. Deprivation and bronchiolitis. Arch Dis Child 1996;74:50-2. (Pubitemid 26039952)
12. Heikkinen T, Valkonen H, Lehtonen L, et al. Hospital admission of high risk infants for respiratory syncytial virus infection: implications for palivizumab prophylaxis. Arch Dis Child Fetal Neonatal Ed 2005;90:F64-8. (Pubitemid 40040210)
13. Kennedy N, Flanagan N. Is nasogastric fl uid therapy a safe alternative to the intravenous route in infants with bronchiolitis? Arch Dis Child 2005;90:320-1.
14. Perrotta C, Ortiz Z, Roque M. Chest physiotherapy for acute bronchiolitis in paediatric patients between 0 and 24 months old. Cochrane Database Syst Rev 2007;1:CD004873.
15. Gajdos V, Katsahian S, Beydon N, et al. Effectiveness of chest physiotherapy in infants hospitalized with acute bronchiolitis: a multicenter, randomized, controlled trial. PLoS Med 2010;7:e1000345.
16. Umoren R, Odey F, Meremikwu MM. Steam inhalation or humidified oxygen for acute bronchiolitis in children up to three years of age. Cochrane Database Syst Rev 2011;1:CD006435.
17. Rojas MX, Granados Rugeles C, Charry-Anzola LP. Oxygen therapy for lower respiratory tract infections in children between 3 months and 15 years of age. Cochrane Database Syst Rev 2009;1:CD005975.
18. Cunningham S, McMurray A. Observational study of two oxygen saturation targets for discharge in bronchiolitis. Arch Dis Child 2012;97:361-3.
19. Donlan M, Fontela PS, Puligandla PS. Use of continuous positive airway pressure (CPAP) in acute viral bronchiolitis: a systematic review. Pediatr Pulmonol 2011;46:736-46.
20. Beasley JM, Jones SE. Continuous positive airway pressure in bronchiolitis. Br Med J (Clin Res Ed) 1981;283:1506-8. (Pubitemid 12235779)
21. Evans J, Marlais M, Abrahamson E. Clinical predictors of nasal continuous positive airway pressure requirement in acute bronchiolitis. Pediatr Pulmonol 2012;47:381-5.
22. McKiernan C, Chua LC, Visintainer PF, et al. High flow nasal cannulae therapy in infants with bronchiolitis. J Pediatr 2010;156:634-8.
23. Hilliard TN, Archer N, Laura H, et al. Pilot study of vapotherm oxygen delivery in moderately severe bronchiolitis. Arch Dis Child 2012;97:182-3.
24. Liet JM, Ducruet T, Gupta V, et al. Heliox inhalation therapy for bronchiolitis in infants. Cochrane Database Syst Rev 2010;4:CD006915.
25. Downes JJ, Wood DW, Striker TW, et al. Acute respiratory failure in infants with bronchiolitis. Anesthesiology 1968;29:426-34.
26. Ventre K, Haroon M, Davison C. Surfactant therapy for bronchiolitis in critically ill infants. Cochrane Database Syst Rev 2006;3:CD005150.
27. Flamant C, Hallalel F, Nolent P, et al. Severe respiratory syncytial virus bronchiolitis in children: from short mechanical ventilation to extracorporeal membrane oxygenation. Eur J Pediatr 2005;164:93-8. (Pubitemid 40311571)
28. Behrendt CE, Decker MD, Burch DJ, et al. International variation in the management of infants hospitalized with respiratory syncytial virus. International RSV Study Group. Eur J Pediatr 1998;157:215-20. (Pubitemid 28113875)
29. Christakis DA, Cowan CA, Garrison MM, et al. Variation in inpatient diagnostic testing and management of bronchiolitis. Pediatrics 2005;115:878-84.
30. van Dellen QM, Kreier F, de Kruiff CC, et al. Question 2. Does combined oral dexamethasone and epinephrine inhalation help infants with bronchiolitis to recover faster? Arch Dis Child 2011;96:606-8.
31. Hartling L, Fernandes RM, Bialy L, et al. Steroids and bronchodilators for acute bronchiolitis in the first two years of life: systematic review and meta-analysis. BMJ 2011;342:d1714.
32. Flores G, Horwitz RI. Effi cacy of beta2-agonists in bronchiolitis: a reappraisal and meta-analysis. Pediatrics 1997;100:233-9.
33. Gadomski AM, Bhasale AL. Bronchodilators for bronchiolitis. Cochrane Database Syst Rev 2006;3:CD001266.
34. Everard ML, Bara A, Kurian M, et al. Anticholinergic drugs for wheeze in children under the age of two years. Cochrane Database Syst Rev 2005;3:CD001279.
35. Wohl ME, Chernick V. State of the art: bronchiolitis. Am Rev Respir Dis 1978;118:759-81.
36. Hartling L, Bialy LM, Vandermeer B, et al. Epinephrine for bronchiolitis. Cochrane Database Syst Rev 2011;6:CD003123.
37. Corneli HM, Zorc JJ, Mahajan P, et al. A multicenter, randomized, controlled trial of dexamethasone for bronchiolitis. N Engl J Med 2007;357:331-9. (Pubitemid 47124133)
38. Fernandes RM, Bialy LM, Vandermeer B, et al. Glucocorticoids for acute viral bronchiolitis in infants and young children. Cochrane Database Syst Rev 2010;10:CD004878.
39. Plint AC, Johnson DW, Patel H, et al. Epinephrine and dexamethasone in children with bronchiolitis. N Engl J Med 2009;360:2079-89.
40. Spurling GK, Doust J, Del Mar CB, et al. Antibiotics for bronchiolitis in children. Cochrane Database Syst Rev 2011;6:CD005189.
41. Thorburn K, Harigopal S, Reddy V, et al. High incidence of pulmonary bacterial co-infection in children with severe respiratory syncytial virus (RSV) bronchiolitis. Thorax 2006;61:611-15. (Pubitemid 44035142)
42. Ventre K, Randolph AG. Ribavirin for respiratory syncytial virus infection of the lower respiratory tract in infants and young children. Cochrane Database Syst Rev 2007;1:CD000181.
43. Mandelberg A, Amirav I. Hypertonic saline or high volume normal saline for viral bronchiolitis: mechanisms and rationale. Pediatr Pulmonol 2010;45:36-40.
44. Zhang L, Mendoza-Sassi RA, Wainwright C, et al. Nebulized hypertonic saline solution for acute bronchiolitis in infants. Cochrane Database Syst Rev 2008;4:CD006458.
45. Nasr SZ, Strouse PJ, Soskolne E, et al. Effi cacy of recombinant human deoxyribonuclease I in the hospital management of respiratory syncytial virus bronchiolitis. Chest 2001;120:203-8. (Pubitemid 32744880)
46. Boogaard R, Hulsmann AR, van Veen L, et al. Recombinant human deoxyribonuclease in infants with respiratory syncytial virus bronchiolitis. Chest 2007;131:788-95. (Pubitemid 46446871)
47. Bisgaard H. Montelukast in RSV-bronchiolitis. Am J Respir Crit Care Med 2004;169:542-3.
48. Ramesh P, Samuels M. Are methylxanthines effective in preventing or reducing apnoeic spells in infants with bronchiolitis? Arch Dis Child 2005;90:321-2.